EOS100850 (Inupadenant)

Inupadenant · iTeos Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EOS100850 (Inupadenant), covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer [Phase 1]